2021
DOI: 10.1021/acs.jcim.0c01494
|View full text |Cite
|
Sign up to set email alerts
|

De Novo Molecule Design Through the Molecular Generative Model Conditioned by 3D Information of Protein Binding Sites

Abstract: De novo molecule design through molecular generative model is gaining increasing attention in recent years. Here a novel generative model was proposed by integrating the 3D structural information of the protein binding pocket into the conditional RNN (cRNN) model to control the generation of drug-like molecules. In this model, the composition of protein binding pocket is effectively characterized through a coarse-grain strategy and the threedimensional information of the pocket can be represented by the sorted… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(39 citation statements)
references
References 49 publications
0
34
0
Order By: Relevance
“…Pocket2Drug can be improved by incorporating reinforcement learning imposing additional restraints on the synthetic accessibility, solubility, and toxicity of generated molecules, depending on a specific application. Additional improvements can also be achieved by applying a framework similar to the conditional recurrent neural network (cRNN), utilizing the RNN with the prior information ( Xu et al, 2021 ), to the heterogeneous input data. In contrast to cRNN, in which the pre-computed information is used as the prior condition for RNN, Pocket2Drug is an end-to-end DNN, therefore the encoder is updated during training.…”
Section: Discussionmentioning
confidence: 99%
“…Pocket2Drug can be improved by incorporating reinforcement learning imposing additional restraints on the synthetic accessibility, solubility, and toxicity of generated molecules, depending on a specific application. Additional improvements can also be achieved by applying a framework similar to the conditional recurrent neural network (cRNN), utilizing the RNN with the prior information ( Xu et al, 2021 ), to the heterogeneous input data. In contrast to cRNN, in which the pre-computed information is used as the prior condition for RNN, Pocket2Drug is an end-to-end DNN, therefore the encoder is updated during training.…”
Section: Discussionmentioning
confidence: 99%
“…Skalic et al (2019) employed a modified GAN model, named BicycleGAN (Zhu et al, 2017), to represent molecules in the hidden space from protein pockets and decode the representations to SMILES strings using a captioning network. Another representative work by Xu et al (2021) designed two structure descriptors to encode the pocket and generated SMILES using conditional RNN. However, these methods merely generate 1D SMILES strings or 2D molecular graphs.…”
Section: Related Workmentioning
confidence: 99%
“…Early approaches modify the pocket-free models by integrating evaluation functions like docking scores between sampled molecules and pockets to guide the candidate searching (Li et al, 2021). Another types of models transform the 3D pocket structures to molecular SMILES strings or 2D molecular graph (Skalic et al, 2019;Xu et al, 2021) without modeling the interactions between the small molecular structures and 3D pockets explicitly. Conditional generative models are developed to model the 3D atomic density distributions within the 3D pocket structures (Masuda et al, 2020;Luo et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, researchers pursue solutions in two directions: (1) reducing the constraints by generating non-3D molecules, in which the molecules are represented as strings (i.e. SMILES) or graphs 8 10 ; (2) expanding the dataset, for example, by generating ligand–protein complex data using docking approaches 11 . Although these attempts are inspiring, a groundbreaking strategy that can pour additional experimental data in the models is still absent.…”
Section: Introductionmentioning
confidence: 99%